PFM Health Sciences’s Illumina ILMN Stock Holding History

PFM Health Sciences’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.16M	Buy	35,040 +6,171	+21%	+$903K	0.53%	60
2026 Q1	$3.56M	Buy	+28,869	New	+$3.79M	0.32%	71
2015 Q3	–	Sell	-250,575	Closed	-$53.2M	–	92
2015 Q2	$53.2M	Sell	250,575 -134,781	-35%	-$26.3M	1.35%	29
2015 Q1	$69.6M	Buy	385,356 +299,360	+348%	+$56.4M	1.92%	19
2014 Q4	$15.4M	Buy	+85,996	New	+$15.2M	0.36%	67
2014 Q1	–	Sell	-96,713	Closed	-$10.4M	–	85
2013 Q4	$10.4M	Buy	+96,713	New	+$8.86M	0.21%	52

Other funds holding ILMN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PFM Health Sciences's ILMN Position: Q2 2026 in Review

PFM Health Sciences increased its Illumina (ILMN) stake by 21% in Q2 2026, buying an estimated $903K and bringing the position to 35,040 shares worth $6.16M. The position accounts for 0.53% of the portfolio, ranked #60.

PFM Health Sciences first reported a position in ILMN in Q4 2013 and has held it in 6 quarters since. The position peaked at $69.6M in Q1 2015. 937 funds tracked by Wall St. Rank hold ILMN as of Q2 2026.

PFM Health Sciences held 35,040 shares of Illumina worth $6.16M as of Q2 2026.
PFM Health Sciences bought 6,171 Illumina shares in Q2 2026, an estimated $903K.
Illumina made up 0.53% of PFM Health Sciences's portfolio in Q2 2026, its #60 holding.
PFM Health Sciences first reported a position in Illumina in Q4 2013 and has held it in 6 quarters since.
PFM Health Sciences's Illumina position peaked at $69.6M in Q1 2015.
937 funds tracked by Wall St. Rank held Illumina as of Q2 2026.

Based on PFM Health Sciences's 13F filing for Q2 2026, filed 14 Aug 2026.